Exercise as prescription therapy: benefits in cancer and hypertensive patients.

Abstract

PURPOSE Exercise therapy in patients with metabolic chronic disease produces several positive response. This study aims to verify the effects of fast walking associated to a resistance exercise to reduce cardiovascular risk factor. Two groups of subjects (10 cancer survivors and 19 hypertensive patients) were evaluated by 6-Minute Walking Test (6MWT), bioimpedance, the Sit & Reach Test (S&R) evaluate the flexibility, Handgrip and 30" Chair Test for muscular strength. Patients were tested before and after 3 months of regular physical exercise. A significant change in anthropometric parameters was observed (BMI: T0 = 29.2±6.8, T3= 27.4±4.4 kg/m2 p<.001; waist circumference: T0=92.5±14.1, T3=92.1±12.8 cm, p<.05) in the hypertensive population. A predominant improvement of the cardiovascular parameters was observed in the cancer survivors (rest DBP T0=76.4±6.5, T3=72.2±7.1 mmhg p<.05; 6MWT: T0=487.8±116.0, T3= 525.6±117.3 m p<.05; S&R: T0= 0.4±7.4, T3=4.1±6.1 cm p<.05). A combined aerobic and resistance exercise programme can improve cardiovascular risk factors in hypertensive subjects. The same programme induces improvement in exercise tolerance and flexibility variables in cancer survivors.